JCRファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/12/11 | 5,350 | 5,470 | 5,210 | 5,220 | -130 | -2.4% | 142,800 |
2018/12/10 | 5,400 | 5,480 | 5,300 | 5,350 | -100 | -1.8% | 88,700 |
2018/12/07 | 5,560 | 5,600 | 5,360 | 5,450 | -70 | -1.3% | 89,000 |
2018/12/06 | 5,670 | 5,700 | 5,460 | 5,520 | -220 | -3.8% | 91,000 |
2018/12/05 | 5,550 | 5,790 | 5,550 | 5,740 | +120 | +2.1% | 97,700 |
2018/12/04 | 5,780 | 5,860 | 5,600 | 5,620 | -210 | -3.6% | 98,200 |
2018/12/03 | 5,980 | 6,010 | 5,760 | 5,830 | +20 | +0.3% | 122,400 |
2018/11/30 | 5,640 | 5,830 | 5,620 | 5,810 | +200 | +3.6% | 136,300 |
2018/11/29 | 5,580 | 5,830 | 5,560 | 5,610 | +120 | +2.2% | 221,200 |
2018/11/28 | 5,370 | 5,550 | 5,340 | 5,490 | +90 | +1.7% | 182,200 |
2018/11/27 | 5,410 | 5,460 | 5,320 | 5,400 | +40 | +0.7% | 81,000 |
2018/11/26 | 5,260 | 5,370 | 5,210 | 5,360 | +70 | +1.3% | 56,100 |
2018/11/22 | 5,250 | 5,300 | 5,140 | 5,290 | +70 | +1.3% | 38,500 |
2018/11/21 | 5,110 | 5,280 | 5,100 | 5,220 | -80 | -1.5% | 64,300 |
2018/11/20 | 5,350 | 5,410 | 5,240 | 5,300 | -150 | -2.8% | 66,900 |
2018/11/19 | 5,070 | 5,460 | 5,060 | 5,450 | +390 | +7.7% | 122,600 |
2018/11/16 | 5,120 | 5,150 | 5,020 | 5,060 | -30 | -0.6% | 64,000 |
2018/11/15 | 5,120 | 5,240 | 5,000 | 5,090 | -100 | -1.9% | 115,600 |
2018/11/14 | 5,350 | 5,400 | 5,170 | 5,190 | -80 | -1.5% | 90,100 |
2018/11/13 | 5,200 | 5,300 | 5,160 | 5,270 | -70 | -1.3% | 131,800 |
2018/11/12 | 5,550 | 5,560 | 5,310 | 5,340 | -260 | -4.6% | 118,500 |
2018/11/09 | 5,740 | 5,770 | 5,510 | 5,600 | -160 | -2.8% | 117,800 |
2018/11/08 | 5,720 | 5,790 | 5,640 | 5,760 | +190 | +3.4% | 117,200 |
2018/11/07 | 5,620 | 5,670 | 5,490 | 5,570 | -50 | -0.9% | 136,700 |
2018/11/06 | 5,440 | 5,660 | 5,400 | 5,620 | +280 | +5.2% | 192,700 |
2018/11/05 | 5,240 | 5,390 | 5,210 | 5,340 | +110 | +2.1% | 188,700 |
2018/11/02 | 4,865 | 5,270 | 4,860 | 5,230 | +475 | +10% | 342,000 |
2018/11/01 | 4,770 | 4,890 | 4,600 | 4,755 | -40 | -0.8% | 275,500 |
2018/10/31 | 4,825 | 4,870 | 4,740 | 4,795 | +40 | +0.8% | 159,300 |
2018/10/30 | 4,775 | 4,850 | 4,665 | 4,755 | -40 | -0.8% | 233,000 |
2018/10/29 | 5,160 | 5,190 | 4,775 | 4,795 | -415 | -8% | 282,100 |
2018/10/26 | 5,540 | 5,580 | 5,210 | 5,210 | -130 | -2.4% | 209,900 |
2018/10/25 | 5,520 | 5,530 | 5,320 | 5,340 | -280 | -5% | 209,200 |
2018/10/24 | 5,780 | 5,800 | 5,620 | 5,620 | -110 | -1.9% | 62,000 |
2018/10/23 | 5,800 | 5,830 | 5,710 | 5,730 | -80 | -1.4% | 87,300 |
2018/10/22 | 5,780 | 5,840 | 5,660 | 5,810 | -20 | -0.3% | 56,600 |
2018/10/19 | 5,690 | 5,860 | 5,610 | 5,830 | +100 | +1.7% | 114,000 |
2018/10/18 | 5,900 | 5,980 | 5,720 | 5,730 | -150 | -2.6% | 105,500 |
2018/10/17 | 5,800 | 5,920 | 5,740 | 5,880 | +220 | +3.9% | 62,400 |
2018/10/16 | 5,660 | 5,750 | 5,580 | 5,660 | -90 | -1.6% | 104,600 |
2018/10/15 | 5,810 | 5,830 | 5,690 | 5,750 | -60 | -1% | 73,400 |
2018/10/12 | 5,630 | 5,820 | 5,620 | 5,810 | +100 | +1.8% | 84,000 |
2018/10/11 | 5,660 | 5,840 | 5,550 | 5,710 | -250 | -4.2% | 138,100 |
2018/10/10 | 5,910 | 6,040 | 5,910 | 5,960 | +40 | +0.7% | 85,300 |
2018/10/09 | 6,120 | 6,190 | 5,880 | 5,920 | -270 | -4.4% | 130,600 |
2018/10/05 | 6,200 | 6,260 | 6,080 | 6,190 | -70 | -1.1% | 100,100 |
2018/10/04 | 6,270 | 6,310 | 6,140 | 6,260 | +50 | +0.8% | 113,500 |
2018/10/03 | 6,320 | 6,360 | 6,200 | 6,210 | -100 | -1.6% | 88,500 |
2018/10/02 | 6,470 | 6,470 | 6,230 | 6,310 | -120 | -1.9% | 159,500 |
2018/10/01 | 6,490 | 6,620 | 6,310 | 6,430 | -20 | -0.3% | 261,300 |
1451~
1500
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「JCRファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム